Intraoperative Analysis of Cortisol During Adrenal Vein Sampling
1 other identifier
interventional
21
1 country
1
Brief Summary
Aldosterone is a hormone produced in the adrenals that helps regulate the salt balance and blood pressure. Primary hyperaldosteronism is one of the main endocrine causes of secondary hypertension. The overproduction of aldosteron might in some cases be due to unilateral hyperplasia of the adrenal cortex or a unilateral aldosterone-producing adenoma. In these cases the adrenal can be removed and the patient cured of hypertension. The clinical evaluation of patients with confirmed primary hyperaldosteronism therefore includes selective sampling of blood from the adrenal veins to determine lateralization of overproduction. This is executed as an interventional radiological procedure. The adrenal vein sampling is challenging, and success is determined by measuring another adrenal hormone named cortisol in the blood samples as a marker of a correctly drawn sample. By routine laboratory assays the procedure is evaluated after the patient has been discharged from the hospital. In the study a rapid assay of cortisol will be evaluated, allowing the radiologist to draw new samples during the same procedure if the first set of samples is unsuccessful. The study hypothesis is that intraoperative measurement of cortisol is a useful tool to evaluate successful sampling, and that fewer patients will need a repeated procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 2, 2013
CompletedFirst Posted
Study publicly available on registry
January 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedAugust 29, 2013
August 1, 2013
4 months
January 2, 2013
August 28, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Representative blood sample from adrenal veins bilaterally.
Patients where the drawn blood from both adrenal veins is representative is the primary endpoint.
Intraoperatively
Study Arms (1)
Intraoperative measurement of cortisol
EXPERIMENTALIntervention: During a routine procedure intraoperative cortisol is measured. Upon unsuccessful sampling, the sampling will be repeated.
Interventions
Levels of cortisol in blood samples will be determined using a rapid cortisol assay. This is not standard procedure
Eligibility Criteria
You may qualify if:
- Primary hyperaldosteronism
- Motivated for surgery if applicable
- Able to give informed consent
You may not qualify if:
- Not able to give informed consent
- Severe kidney failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haukeland University Hospital
Bergen, Hordaland, 5020, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gunnar Mellgren, MD.PhD
Hormonlaboratoriet, Haukeland Universitetssykehus
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2013
First Posted
January 4, 2013
Study Start
January 1, 2013
Primary Completion
May 1, 2013
Study Completion
August 1, 2013
Last Updated
August 29, 2013
Record last verified: 2013-08